The purpose of this retrospective study was to clarify the predictive factors correlated with esophageal stenosis within three months after radiation therapy for locally advanced esophageal cancer. We enrolled 47 patients with advanced esophageal cancer with T2-4 and stageII-III who were treated with definitive radiation therapy and achieving complete response of primary lesion at Kyushu University Hospital between January 1998 and December 2005. Esophagography was performed for all patients before treatment and within three months after completion of the radiation therapy, the esophageal stenotic ratio was evaluated. The stenotic ratio was used to define four levels of stenosis: stenosis level 1, stenotic ratio of 0-25%; 2, 25-50%; 3,50-75%; 4,75-100%. We then estimated the correlation between the esophageal stenosis level after radiation therapy and each of numerous factors. The numbers and total percentages of patients at each stenosis level were as follows: level 1: n = 14 (30%); level 2: 8 (17%); level 3: 14 (30%); and level 4: 11 (23%). Esophageal stenosis in the case of full circumference involvement tended to be more severe and more frequent. Increases in wall thickness tended to be associated with increases in esophageal stenosis severity and frequency. The extent of involved circumference and wall thickness of tumor region were significantly correlated with esophageal stenosis associated with tumor regression in radiation therapy (p = 0.0006, p = 0.005). For predicting the possibility of esophageal stenosis with tumor regression within three months in radiation therapy, the extent of involved circumference and esophageal wall thickness of the tumor region may be useful.
INTRODUCTION
Among solid-tumor type cancers, esophageal cancer has one of the highest mortality rates. Advanced esophageal cancer is treated with a multidisciplinary approach: surgery, radiation therapy and chemotherapy. Surgery has been accepted as a standard treatment for resectable locally advanced esophageal cancer, while radiation therapy has been accepted as the standard therapy for unresectable or inoperable locally advanced esophageal cancer. Recently, with the development of chemoradiation, some reports have indicated that definitive chemoradiation has a curative potential for locally advanced esophageal cancer and may be considered equivalent to surgery in terms of its survival benefit. [1] [2] [3] [4] [5] [6] [7] In some cases, however, the esophageal stenosis worsens during the course of radiation therapy, despite the reduction in tumor size. If the esophageal stenosis increases the patients may experience dysphagia and oral intake disorders, which can substantially decrease their quality of life (QOL). There have been several reports on the risk factors or mechanism of esophageal stenosis after radiation therapy for locally advanced esophageal cancer. However, there has been no study examining the frequency or degree of esophageal stenosis in such cases.
The purpose of this retrospective study was to clarify the factors correlated with esophageal stenosis within three months after radiation therapy for locally advanced esophageal cancer. The "esophageal stenosis" used in this study dose not mean a late toxicity but stenotic change which sometimes occurred with tumor shrinkage responded to radiation therapy.
MATERIALS AND METHODS

Patients
We enrolled 47 patients (43 males and 4 females) with advanced esophageal cancer with T2-4 and stageII-III treated with definitive radiation therapy with/without concurrent chemotherapy achieving complete response of primary lesion at Kyushu University Hospital between January 1998 and December 2005. The characteristics of the patients are shown in Table 1 . The patients' ages ranged from 50 to 87 years (mean: 70 years). In all patients, pathological examination of the specimen obtained by biopsy revealed squamous call carcinoma (SCC). Written informed consent was obtained from all patients enrolled in this retrospective study.
Pretreatment evaluation
The extent of disease in each patient was evaluated by physical examination, esophagography, esophagoscopy and computed tomography (CT) of the neck, chest and abdomen. Bronchoscopy was performed when tracheobronchial involvement was suspected. Endoscopic ultrasound (EUS) was applied when the transducer could pass through the tumor. Assignment of clinical staging and tumor finding type was performed according to the criteria of the International Union against Cancer (UICC, 1997).
8) The tumor finding type was evaluated by the criteria of the Japanese Society for Esophageal Diseases, which were based on the findings from esophagograms and esophagoscopy.
9) The extent of involved circumference and the tumor length were evaluated with esophagography and esophagoscopy, and wall thickness was evaluated with contrasted enhanced CT images before radiation therapy by measuring the thickness of the thickest portion of the tumor. The degree of stenosis before treatment was also evaluated with esophagography by the method described below. These characteristics of are summarized in Table 1 .
Treatments
In all patients, radiation therapy was performed using an external beam and delivered at a daily dose of 1.8-2 Gy, five times per week with a Varian 21EX (Varian Medical Systems, Palo Alto, CA) linear accelerator. The regional RT was delivered through anteroposterior portals using 4, 6 or 10 MV photon beams with a T-shape field including the bilateral supraclavicular, mediastinal and abdominal regional lymph nodes or I-shape field including mediastinal and abdominal regional lymphnode to 40-41.4 Gy, and the boost was delivered through parallel opposed oblique portals avoiding spinal cord using 10 MV photon beams. The total dose ranged from 50.4 to 76 Gy (median 65 Gy). 39 patients were treated with radiation and concurrent chemotherapy and 8 were treated with radiation alone (Table 1 ). The concurrent chemotherapy regimen consisted of cisplatin or carboplatin plus 5-fluorourasil. No patients was performed a procedure like balloon dilatation or insertion of esophageal stent against esophageal stenosis before radiotherapy.
Response evaluation
The response was determined within three month following the completion of treatment by using esophagography and esophagoscopy. The response of the primary tumor was evaluated by the criteria of the Japanese Society for Esophageal Diseases, which were based on the findings from esophagograms and esophagoscopy. 9) CR was defined based on findings from esophagograms and esophagoscopy as disappearance of the tumor lesion and disappearance of ulceration. 
Evaluation of esophageal stenosis
We evaluated the stenotic ratio using the image of esophagography before and within three months after the completion of radiation therapy by the method shown in Fig. 1 . Using an image in which stenotic change was mostly reflected among the esophagography series, we measured the lumen diameter at the narrowest part of (b) and the widest part of the oral side of the (a) of the primary site after radiation therapy. The esophageal stenotic ratio (c) (expressed as a percentage) was calculated as c = (a -b) / a*100. The definition of stenosis levels was shown in Table 2 ; the stenotic ratio was used to define four stenosis levels: stenosis level 1, stenotic ratio of 0-24%; 2, 25-49%; 3, 50-74%; 4, 75-100%.
Statistical analysis
We estimated the correlation between the esophageal stenosis level after radiation therapy and each of numerous factors about tumors and therapy; age, gender, T stage, extent of involved circumference, length and wall thickness of the tumor region, stenosis level before treatment, total dose of radiation therapy and with/ without concurrent chemotherapy. For univariate analysis, a chisquare test was performed to compare the distribution of the characteristics of patients and treatments among the stenosis levels. For multivariate analysis, logistic regression analysis was performed. Differences were considered statistically significant when p < 0.05.
RESULTS
The number and percentage of patients with each level of stenosis is shown in Table 2 : stenosis level 1: n = 14 patients (30%); level 2: 8 (17%);, level 3:14 (30%); and level 4:11 (23%). The summary of correlation between each factors and the proportion of patients with each stenosis level was shown in Table 3 . In regard to the extent of involved circumference, the proportion of patients with level 4 stenosis were 8% and 45% of the case of non-full and full circumference involvement. Esophageal stenosis in the cases of full circumference involvement tended to be more severe and more frequent than that in the cases of non-full circumference involvement. Among cases with a tumor thickness of less than 10 mm, more than 10 mm, the proportions of patients with level 4 stenosis were 0% and 38%, respectively. Increases in wall thickness tended to be associated with increases in esophageal stenosis severity and frequency.
The results of the statistical analysis are summarized in Table 3 . In the univariate analysis, significant differences appeared for T stage, the wall thickness of tumor region, the extent of involved circumference and stenosis level before treatment (p < 0.05), and significant associations were not seen for age, gender, tumor length, radiation total dose and concurrent chemotherapy. In the multivariate analysis, significant differences appeared for the wall thickness of tumor region and the extent of involved circumference (p = 0.005, p = 0.0006). The extent of involved circumference and wall thickness of tumor region were significantly correlated with esophageal stenosis associated with tumor regression in radiation therapy.
DISCUSSION
For esophageal cancer, surgical resection has been widely accepted as the standard treatment. [10] [11] This treatment has been associated with subsequent mortality, high complication rates and quality of life deterioration. [12] [13] [14] Long-term survival after resection of esophageal cancer is generally poor, with a 20-42.4% 5-year survival rate. [15] [16] [17] [18] Both radiation therapy and surgery have been shown to be useful therapies for locally advanced esophageal cancer. The histological type of most esophageal cancers is SCC, Fig. 1 . Esophagography image. We measured the lumen diameter of the narrowest part (b) and the widest part of the oral side (a) of the primary site after radiation therapy. The esophageal stenotic ratio (c) (presented as a percentage) was calculated as c = (a -b) / a*100. which is considered to have high radiosensitivity. Some reports on chemoradiation have indicated various advantages of this modality for managing esophageal cancer. 1-4), [19] [20] [21] [22] Oncologists advocate that a nonsurgical approach with definitive chemoradiotherapy may be the standard for this disease. [23] [24] [25] [26] Recently, some reports have suggested that chemoradiation may be considered equivalent to surgery in terms of survival. [5] [6] [7] It may thus be necessary to select among surgery, definitive chemoradiotherapy, and chemoradiation on an individual patient basis.
Dysphagia due to esophageal stenosis is often observed after radiation therapy, and esophageal stenosis decreases QOL of patients after radiation therapy, and can often lead to dysphagia. Abbreviations: Ce = cervical esophagus; Ut = upper thoracic esophagus; Mt = middle thoracic esophagus; Lt = lower thoracic esophagus; Ae = abdominal esophagus After completion of the radiation therapy, in some cases the tumor size was reduced and esophageal narrowing was improved, but in other cases the esophageal stenosis worsened despite the reduction in tumor size. If the esophageal stenosis increases, patients will experience dysphagia, and oral intake may become difficult for them. If oral intake becomes impossible, intervention is immediately needed to decrease the stenosis. As palliative procedures against esophageal stenosis, balloon dilatation, endoscopic placement of esophageal stents, and bypass operations have been performed. Simple balloon dilatation is considered safe, but the probability of re-stenosis is high. Endoscopic placement of esophageal stents is the most widely used palliative treatment for patients with esophageal stenosis or fistula, but some reports have suggested that it has a high rate of severe complications (perforation, fistula, bleeding, etc.) that can lead immediately to death, especially when esophageal intuvation is combined with radiation therapy and the patients with complications took food for shorter periods than those who had no complication. [27] [28] [29] [30] [31] [32] [33] A bypass operation is considered very risky. Therefore, although there are numerous palliative, procedures against esophageal stenosis, their outcome are not yet satisfactory.
It is considered that esophageal stenosis after radiation therapy may be caused by fibrosis or ischemic change of the process of tumor reduction, but the details have not been clarified yet. Nonetheless, a few reports have proposed possible mechanisms or frequencies for esophageal stenosis after radiation therapy. [34] [35] [36] [37] These reports have suggested that patients with dysphagia after radiation therapy to the chest and neck show histologic evidence of fibrosis of the submucosa and hyalinization of the smooth muscle layers of the esophagus, 34) and these processes include the accumulation of macrophages and increased local levels of pro-inflammatory cytokines, 35, 36) producing edema and fibrosis that may secondarily affect the underlying muscles. 37) In this study, in order to predict the possibility of esophageal stenosis after radiation therapy, the extent of involved circumference and the wall thickness of tumor region may be useful. If we could predict the degree of esophageal stenosis after radiation therapy, this would be useful in various contexts-e.g., for the selection of therapy (definitive chemoradiation or surgical resection) or for obtaining informed consent for the patient before radiation therapy. Additionally, in operable cases, if we could predict that severe esophageal stenosis will occur after radiation therapy, it would be possible to prevent or avoid the stenosis and reduce patients' concerns over this very problematic side effect.
In conclusion, for predicting the possibility of esophageal stenosis associated with tumor regression within three months in radiation therapy, the extent of involved circumference and esophageal wall thickness of the tumor region may be useful.
